Advances in Thoracic Oncology Conference Focuses on Mesothelioma Treatment

Treatment & Doctors
Reading Time: 4 mins
Publication Date: 04/03/2014
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article

APA

Povtak, T. (2020, October 16). Advances in Thoracic Oncology Conference Focuses on Mesothelioma Treatment. Asbestos.com. Retrieved February 8, 2023, from https://www.asbestos.com/news/2014/04/03/fox-chase-cancer-conference/

MLA

Povtak, Tim. "Advances in Thoracic Oncology Conference Focuses on Mesothelioma Treatment." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/news/2014/04/03/fox-chase-cancer-conference/.

Chicago

Povtak, Tim. "Advances in Thoracic Oncology Conference Focuses on Mesothelioma Treatment." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/news/2014/04/03/fox-chase-cancer-conference/.

The Fox Chase Cancer Center in Philadelphia doesn’t handle as many pleural mesothelioma cases as some of the other specialty centers, but the care it provides them and outcomes it produces are second to none.

Mesothelioma cancer is a high priority.

“I don’t think you can get better care anywhere else,” said Walter Scott, M.D., chief of thoracic surgical oncology at Fox Chase. “We’ve got the experts with experience. And we’ve got that great support team around them.”

Scott spoke at the conclusion of the sixth annual Advances in Thoracic Oncology Conference last week. The program, which included presenters from Fox Chase and other specialty centers, was aimed at medical professionals and focused on the latest advances in mesothelioma treatment. The audience included surgeons, radiation oncologists, pulmonologists, physician assistants and nurses, including Karen Selby, our nurse at The Mesothelioma Center.

Growing Hope for Mesothelioma

Prashant Shah, M.D., thoracic surgeon at Fox Chase, told Asbestos.com, “There is real reason for hope now with mesothelioma.”

“We’re not moving mountains, but we are making steady progress,” Shah said. “There still is a long way to go, but we’ve come a long way, too. Attitudes [toward mesothelioma] are changing.”

Shah spoke on “Strategies for Treatment of the Pleura During Surgery for MPM” (malignant pleural mesothelioma). He touched on the staging system and adjuvant therapies used at Fox; the ongoing debate on whether surgical candidates are better served by the extrapleural pneumonectomy (EPP) or pleurectomy/decortication (P/D); and the future of mesothelioma treatment.

Shah and Stacey Su, M.D., handle the majority of the mesothelioma surgeries at Fox. Both trained in Boston at Brigham and Women’s Hospital under renowned mesothelioma specialist David Sugarbaker.

Fox Chase, which is part of the Temple University Health System, is lauded for its multimodality treatment approach for multiple cancers, including mesothelioma. It is known as a pioneer in lung cancer treatment advances, and it’s now focusing more on asbestos-related cancers.

“I think it’s fair to say we’ve got it all here at Fox Chase,” Scott said. “The care that you’ll receive is better than ever. With mesothelioma, you need an experienced team that understands this disease, and we have that.”

Conference Addresses Numerous Issues

The conference at Fox Chase also included a segment on “State of the Art: Robotic Surgery for Complex Thoracic Cases,” by Robert Cerfolio, M.D., from the University of Alabama at Birmingham. He has used robotics extensively for more than a decade, though not necessarily for mesothelioma surgeries.

“Robotics is the future of surgery,” Cerfolio said. “Change isn’t always easy, but it’s about doing what is right for our patients.”

Radiation oncologist Kenneth Rosenzweig, M.D., who handles many of the mesothelioma cases at Mount Sinai Hospital in New York, spoke on “Novel Radiotherapy Approaches for MPM.”

He, too, talked about the importance of experience when treating mesothelioma, a rare cancer that is diagnosed in an estimated 3,000 people annually in the U.S. It is particularly important now with the latest Intensity Modulated Radiation Therapy (IMRT), which is used in combination with both aggressive surgical options and for patients who are not surgical candidates.

IMRT — if delivered correctly — kills remaining tumor cells and reduces the risk to surrounding healthy tissue and nearby organs.

Rosenzweig also talked about the latest pre-surgery radiation done in Toronto with patients undergoing the aggressive EPP, which removes an entire lung. Neither Mount Sinai nor Fox Chase is using that radiation approach yet, but they are following it closely.

He was optimistic, yet cautious, when discussing the future of mesothelioma treatment. He is now seeing patients he first treated four, five and six years before. People are living longer than ever.

“My personal approach [to treatment], has evolved. It’s tough with this disease to say we’ve had any big victories or that we’ve figured it out, but things are getting better,” Rosenzweig said. “We’re seeing successes.”

Conferences like the one at Fox Chase, where novel therapies and recent advancements are discussed, are helping the cause. There also were presentations on immunotherapy, molecular testing and palliative care, all designed to help medical professionals help their patients.

“There still is a long fight ahead,” Shah said. “But we’re moving in the right direction.”

open book icon vector illustration
Medically Reviewed by Top Mesothelioma Doctors
Free Mesothelioma Guide